{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:11:35Z","timestamp":1789823495274,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bcmd.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T07:23:11Z","timestamp":1486106591000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A systematic review of the literature for severity predictors in children with sickle cell anemia"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7837-9239","authenticated-orcid":false,"given":"Emily Riehm","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross M.","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0419-2735","authenticated-orcid":false,"given":"Paul R.","family":"Levett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2017.01.014_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705779","article-title":"Has stem cell transplantation come of age in the treatment of sickle cell disease?","volume":"40","author":"Shenoy","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.14167","article-title":"Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches","volume":"174","author":"Arnold","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease","volume":"342","author":"Miller","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2007-07-100719","article-title":"Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort","volume":"111","author":"Quinn","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0035","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0040","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2012-03-419879","article-title":"Impact of hydroxyurea on clinical events in the BABY HUG trial","volume":"120","author":"Thornburg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/asheducation-2011.1.434","article-title":"Primary prophylaxis in sickle cell disease: is it feasible? Is it effective?","volume":"2011","author":"Thompson","year":"2011","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood-2014-05-575209","article-title":"The ethics of a proposed study of hematopoietic stem cell transplant for children with \u201cless severe\u201d sickle cell disease","volume":"124","author":"Nickel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0065","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1182\/blood-2013-01-435776","article-title":"Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia","volume":"123","author":"King","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0070","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0080","first-page":"179","article-title":"The influence of fetal hemoglobin on clinical and hematological variables of children and adolescents with sickle cell anemia in Basra, Southern Iraq","volume":"7","author":"Badr","year":"2015","journal-title":"Iranian J. Blood Cancer"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.67.4.517","article-title":"Fetal haemoglobin and early manifestations of homozygous sickle cell disease","volume":"67","author":"Bailey","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0090","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1182\/blood-2008-03-143891","article-title":"G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia","volume":"112","author":"Bernaudin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0095","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/pbc.24588","article-title":"Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia","volume":"60","author":"Bhatnagar","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0100","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2011-05-349621","article-title":"Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0105","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1542\/peds.103.3.640","article-title":"Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease","volume":"103","author":"Kinney","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajmg.1320270305","article-title":"The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia","volume":"27","author":"Odenheimer","year":"1987","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajh.23457","article-title":"Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes","volume":"88","author":"Sheehan","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ejh.12411","article-title":"Sickle cell disease in children: chronic complications and search of predictive factors for adverse outcomes","volume":"94","author":"Silva","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(81)80529-X","article-title":"Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood","volume":"98","author":"Stevens","year":"1981","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0895-4356(96)00320-4","article-title":"Benign clinical course in homozygous sickle cell disease: a search for predictors","volume":"50","author":"Thomas","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0135","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1093\/hmg\/ddp401","article-title":"Control of fetal hemoglobin: new insights emerging from genomics and clinical implications","volume":"18","author":"Thein","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.2830450402","article-title":"Alpha thalassemia and stroke risk in sickle cell anemia","volume":"45","author":"Adams","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0145","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/03630269.2010.526003","article-title":"Coinheritance of alpha-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia","volume":"34","author":"Belisario","year":"2010","journal-title":"Hemoglobin"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cyto.2011.07.002","article-title":"TNF-alpha and IL-8: serum levels and gene polymorphisms (\u2212308G>A and \u2212251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia","volume":"56","author":"Cajado","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/S0004-282X2011000400004","article-title":"Genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro, Brazil","volume":"69","author":"Filho","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0160","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1182\/blood-2011-01-332205","article-title":"Genetic predictors for stroke in children with sickle cell anemia","volume":"117","author":"Flanagan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200308000-00007","article-title":"The Cooperative Study of Sickle Cell, alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia","volume":"25","author":"Hsu","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0170","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ejh.12607","article-title":"G6PD deficiency and absence of alpha-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia","volume":"96","author":"Joly","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.1103","article-title":"Molecular characteristics of pediatric patients with sickle cell anemia and stroke","volume":"67","author":"Sarnaik","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/bjh.12034","article-title":"Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia","volume":"159","author":"Thangarajh","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000320271","article-title":"\u03b2-Globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or S\u03b2-thalassemia and their association with clinical and hematological features","volume":"124","author":"Belis\u00e1rio","year":"2010","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0190","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070794","article-title":"Increased reticulocytosis during infancy is associated with increased hospitalizations in sickle cell anemia patients during the first three years of life","volume":"8","author":"Meier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0200","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ajh.23777","article-title":"Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease","volume":"89","author":"Meier","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/pbc.22680","article-title":"High reticulocyte count is an independent risk factor for cerebrovascular disease in children with sickle cell anemia","volume":"56","author":"Silva","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.410420505","article-title":"Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler","volume":"42","author":"Adams","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0215","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2006-01-011072","article-title":"Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia","volume":"108","author":"Boyd","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0220","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ajh.21275","article-title":"Sibling history of asthma is a risk factor for pain in children with sickle cell anemia","volume":"83","author":"Field","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpeds.2006.06.038","article-title":"Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia","volume":"149","author":"Uong","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0230","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.21264","article-title":"UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia","volume":"83","author":"Carpenter","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0235","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0240","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1365-2141.2001.02997.x","article-title":"A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia","volume":"114","author":"Hoppe","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0245","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/STROKEAHA.107.483115","article-title":"I. Stroke prevention trial in sickle cell anemia, confirmation of an association between the TNF(\u2212308) promoter polymorphism and stroke risk in children with sickle cell anemia","volume":"38","author":"Hoppe","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0250","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cyto.2012.05.017","article-title":"Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia","volume":"60","author":"Hyacinth","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0255","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1002\/ajh.23819","article-title":"Factors predicting future ACS episodes in children with sickle cell anemia","volume":"89","author":"DeBaun","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0260","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2141.2009.07652.x","article-title":"Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia","volume":"145","author":"Quinn","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ajh.23959","article-title":"Increased risk of severe vaso-occlusive episodes after initial acute chest syndrome in children with sickle cell anemia <4years old: sleep and asthma cohort","volume":"90","author":"Vance","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0197-2456(97)00099-8","article-title":"Stroke prevention trial in sickle cell anemia","volume":"19","author":"Adams","year":"1998","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2141.2006.06193.x","article-title":"Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial","volume":"134","author":"Kwiatkowski","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0285","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0290","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1056\/NEJM198801143180207","article-title":"Levels of fetal hemoglobin necessary for treatment of sickle cell disease","volume":"318","author":"Noguchi","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.22643","article-title":"Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood","volume":"56","author":"Meier","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0300","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pbc.21612","article-title":"MRI abnormalities of the brain in one-year-old children with sickle cell anemia","volume":"51","author":"Wang","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0305","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.1997.tb12032.x","article-title":"The Kleihauer technique: an accurate method of quantifying fetomaternal haemorrhage?","volume":"104","author":"Duckett","year":"1997","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cyto.10154","article-title":"Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection","volume":"50","author":"Chen","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0315","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0320","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.11213","article-title":"Asthma is associated with increased mortality in individuals with sickle cell anemia","volume":"92","author":"Boyd","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0325","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015032","article-title":"The search for genetic modifiers of disease severity in the beta-hemoglobinopathies","volume":"2","author":"Lettre","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bcmd.2017.01.014_bb0330","series-title":"Evidence-based Management of Sickle Cell Disease: Expert Panel Report, 2014","author":"National Heart Lung and Blood Institute (NHLBI)","year":"2014"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0335","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bcmd.2017.01.014_bb0340","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616301383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616301383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:02Z","timestamp":1761049982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616301383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":68,"alternative-id":["S1079979616301383"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.01.014","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the literature for severity predictors in children with sickle cell anemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}